跳至主要内容
临床试验/NCT05924945
NCT05924945终止不适用

Impact of Bridge™ Device as a Non-pharmacological Approach to Treat Opioid Withdrawal in Opioid Use Disorder (OUD) Subjects in an Inpatient Treatment Center

Masimo Corporation2 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2023年6月8日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
13
试验地点
2
主要终点
Assess Change in Clinical Opiate Withdrawal Scale (COWS) Score

研究概览

简要总结

The purpose of this prospective study is to investigate the efficacy of the Bridge™ device in reducing the symptoms of opioid withdrawal in a blind comparison to a sham device.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

A randomization table will be kept with the sponsor. Subjects and study site staff (investigators, researchers, care providers) will be blinded to the group assignment.

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant able to provide written informed consent
  • Participant is 18 to 65-years old
  • Participant has confirmed opioid use disorder (OUD) as defined by the Diagnostic and Statistical Manual of Mental Disorders-5
  • Participants is entering an OUD treatment program

排除标准

  • Participant requires tapering from another substance at entry to treatment
  • Participant is pregnant or lactating
  • Participant has a history of hemophilia or psoriasis vulgaris
  • Participant has a cardiac pacemaker implant device
  • Participant has irritated or broken skin at the site of intended device placement
  • Participant is currently participating in, or was enrolled in another clinical trial within the last 30 days
  • Participant has a history of poor wound healing
  • Participant has a severe autoimmune disease or uncontrolled diabetes
  • Participant has an open wound/abscess infection/MRSA
  • Participant has a history of a chronic pain in the last 90 days
  • Participant has a serious medical condition which in the judgment of the principal investigator or his/her designee would make study participation unsafe, or would make intervention compliance difficult
  • Participant has a psychiatric illness (bipolar disorder, schizophrenia, or other psychotic disorder, active suicidal ideation with a plan within the last month or suicide attempt)

结局指标

主要结局

Assess Change in Clinical Opiate Withdrawal Scale (COWS) Score

时间窗: prior to device placement (0 min), 30 min, 60 min, 120 min, 2nd day, 3rd day, 4th day and 5th day of continuous device use

The Clinical Opiate Withdrawal Scale (COWS) is an 11-item scale designed to be administered by a clinician. This tool can be used in both inpatient and outpatient settings to reproducibly rate common signs and symptoms of opiate withdrawal and monitor these symptoms over time. The summed score for the complete scale can be used to help clinicians determine the stage or severity of opiate withdrawal and assess the level of physical dependence on opioids. Score Range: The COWS score can range from 0 to 48. Interpretation: 0-4: No withdrawal 5-12: Mild withdrawal 13-24: Moderate withdrawal 25-36: Moderately severe withdrawal 37-48: Severe withdrawal High scores mean more severe withdrawal.

次要结局

  • Assess Change in Subjective Opiate Withdrawal Scale (SOWS) Score(prior to device placement (0 min), 30 min, 60 min, 120 min, 2nd day, 3rd day, 4th day and 5th day of continuous device use)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验